Area of research
Hematology · Cancer Research
Research interest
Research interests include Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Protein Degradation and Inhibitors, and Chronic Myeloid Leukemia Treatments.
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with <i>NPM1</i>‐mutated AML
Measurable residual disease monitoring in AML with <i>FLT3</i>-ITD treated with intensive chemotherapy plus midostaurin
A high proportion of germline variants in pediatric chronic myeloid leukemia
The Genomic Landscape and Its Clinical Implication in <i>NPM1</i>-Mutated AML Patients: A Study within the AMLSG 09-09 Clinical Trial
Clonal evolution of acute myeloid leukemia with <i>FLT3</i>-ITD mutation under treatment with midostaurin
Next-Generation Sequencing (NGS)-Based Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia with <i>FLT3</i> Internal Tandem Duplication (<i>FLT3</i>-ITD+ AML) Treated with Additional Midostaurin
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation